287 related articles for article (PubMed ID: 19141651)
41. Activity of steroid sulphatase and estrogen sulphotransferase in the boar epididymis during the postpubertal period.
Zduńczyk S; Janowski T; Raś A; Barański W
Reprod Biol; 2012 Dec; 12(4):374-8. PubMed ID: 23229010
[TBL] [Abstract][Full Text] [Related]
42. Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase.
González A; Martínez-Campa C; Alonso-González C; Cos S
Int J Mol Med; 2015 Dec; 36(6):1671-6. PubMed ID: 26458420
[TBL] [Abstract][Full Text] [Related]
43. The sulfatase pathway as estrogen supply in endometrial cancer.
Cornel KMC; Delvoux B; Saya T; Xanthoulea S; Konings GFJ; Kruitwagen RPFM; Bongers MY; Kooreman L; Romano A
Steroids; 2018 Nov; 139():45-52. PubMed ID: 30217785
[TBL] [Abstract][Full Text] [Related]
44. Intratumoral estrogen production in breast carcinoma: significance of aromatase.
Suzuki T; Miki Y; Ohuchi N; Sasano H
Breast Cancer; 2008; 15(4):270-7. PubMed ID: 18622573
[TBL] [Abstract][Full Text] [Related]
45. [Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Bochkareva NV; Kolomiets LA; Kondakova IV; Stukanov SL; Tropina TV; Muntian AB
Vopr Onkol; 2008; 54(6):729-33. PubMed ID: 19241848
[TBL] [Abstract][Full Text] [Related]
46. Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
Takagi K; Moriya T; Kurosumi M; Oka K; Miki Y; Ebata A; Toshima T; Tsunekawa S; Takei H; Hirakawa H; Ishida T; Hayashi S; Kurebayashi J; Sasano H; Suzuki T
Horm Cancer; 2013 Feb; 4(1):1-11. PubMed ID: 23096432
[TBL] [Abstract][Full Text] [Related]
47. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
Ren X; Wu X; Hillier SG; Fegan KS; Critchley HO; Mason JI; Sarvi S; Harlow CR
J Steroid Biochem Mol Biol; 2015 Jun; 150():54-63. PubMed ID: 25817828
[TBL] [Abstract][Full Text] [Related]
48. Cdc2 as prognostic marker in stage UICC II colon carcinomas.
Meyer A; Merkel S; Brückl W; Schellerer V; Schildberg C; Campean V; Hohenberger W; Croner RS
Eur J Cancer; 2009 May; 45(8):1466-73. PubMed ID: 19223178
[TBL] [Abstract][Full Text] [Related]
49. [Steroid sulfatase inhibitor].
Nakata T; Ishida H; Shiotsu Y
Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
[TBL] [Abstract][Full Text] [Related]
50. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis.
Hudelist G; Czerwenka K; Keckstein J; Haas C; Fink-Retter A; Gschwantler-Kaulich D; Kubista E; Singer CF
Reprod Sci; 2007 Dec; 14(8):798-805. PubMed ID: 18089598
[TBL] [Abstract][Full Text] [Related]
51. In situ production of estrogens in human breast carcinoma.
Suzuki T; Moriya T; Ishida T; Kimura M; Ohuchi N; Sasano H
Breast Cancer; 2002; 9(4):296-302. PubMed ID: 12459709
[TBL] [Abstract][Full Text] [Related]
52. Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go.
Duncan KA
Front Endocrinol (Lausanne); 2020; 11():345. PubMed ID: 32547495
[TBL] [Abstract][Full Text] [Related]
53. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
[TBL] [Abstract][Full Text] [Related]
54. Expression of enzymes involved in synthesis and metabolism of estradiol in human breast as studied by immunocytochemistry and in situ hybridization.
Li Z; Luu-The V; Poisson-Paré D; Ouellet J; Li S; Labrie F; Pelletier G
Histol Histopathol; 2009 Mar; 24(3):273-82. PubMed ID: 19130396
[TBL] [Abstract][Full Text] [Related]
55. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome.
Leon L; Bacallao K; Gabler F; Romero C; Valladares L; Vega M
Steroids; 2008 Jan; 73(1):88-95. PubMed ID: 17953976
[TBL] [Abstract][Full Text] [Related]
56. Expression of sulfotransferase 1E1 in human prostate as studied by in situ hybridization and immunocytochemistry.
Takase Y; Luu-The V; Poisson-Paré D; Labrie F; Pelletier G
Prostate; 2007 Mar; 67(4):405-9. PubMed ID: 17187396
[TBL] [Abstract][Full Text] [Related]
57. Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.
Her C; Szumlanski C; Aksoy IA; Weinshilboum RM
Drug Metab Dispos; 1996 Dec; 24(12):1328-35. PubMed ID: 8971138
[TBL] [Abstract][Full Text] [Related]
58. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
59. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
60. Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.
Sase T; Suzuki T; Miura K; Shiiba K; Sato I; Nakamura Y; Takagi K; Onodera Y; Miki Y; Watanabe M; Ishida K; Ohnuma S; Sasaki H; Sato R; Karasawa H; Shibata C; Unno M; Sasaki I; Sasano H
Int J Cancer; 2012 Nov; 131(10):2284-93. PubMed ID: 22396198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
